GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Hangzhou
State: Zhejiang
Zip:
Country: China
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Series A | 1 | $22M |
Qiming Venture Partners Qiming Venture Partners |
2/2022 | Series A | $0 |
E Fund Management Co.,LTD. GL Ventures K2VC Kaitai Capital Legend Capital Lilly Asia Ventures Qiming Venture Partners E Fund Management Co.,LTD. GL Ventures K2VC Kaitai Capital Legend Capital Lilly Asia Ventures Qiming Venture Partners |
2/2022 | Series A | 7 | $50M |
E Fund Management Co.,LTD. GL Ventures K2VC Kaitai Capital Legend Capital Lilly Asia Ventures Qiming Venture Partners E Fund Management Co.,LTD. GL Ventures K2VC Kaitai Capital Legend Capital Lilly Asia Ventures Qiming Venture Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|